Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cellular Oncology
Published in: Cellular Oncology 4/2018

01-08-2018 | Correction

Correction to: The versatile role of exosomes in cancer progression: diagnostic and therapeutic implications

Authors: Vignesh Sundararajan, Fazlul H. Sarkar, Thamil Selvee Ramasamy

Published in: Cellular Oncology | Issue 4/2018

Login to get access

Excerpt

Correction to: Cellular Oncology …
Metadata
Title
Correction to: The versatile role of exosomes in cancer progression: diagnostic and therapeutic implications
Authors
Vignesh Sundararajan
Fazlul H. Sarkar
Thamil Selvee Ramasamy
Publication date
01-08-2018
Publisher
Springer Netherlands
Published in
Cellular Oncology / Issue 4/2018
Print ISSN: 2211-3428
Electronic ISSN: 2211-3436
DOI
https://doi.org/10.1007/s13402-018-0396-2

Other articles of this Issue 4/2018

Cellular Oncology 4/2018 Go to the issue

Review

Role of PKM2 in directing the metabolic fate of glucose in cancer: a potential therapeutic target

Original Paper

Identification of subsets of actionable genetic alterations in KRAS-mutant lung cancers using association rule mining

Original Paper

Identification of biomarkers associated with partial epithelial to mesenchymal transition in the secretome of slug over-expressing hepatocellular carcinoma cells

Review

Mutual concessions and compromises between stromal cells and cancer cells: driving tumor development and drug resistance

Report

AAA+ ATPases Reptin and Pontin as potential diagnostic and prognostic biomarkers in salivary gland cancer - a short report

Original Paper

Genome-wide analysis of endogenously expressed ZEB2 binding sites reveals inverse correlations between ZEB2 and GalNAc-transferase GALNT3 in human tumors
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits